Recruiting the entire immune system to attack cancer
Stimulating both major branches of the immune system halts tumor growth more effectively.
Biologists identify brain tumor weakness
Discovery could offer a new target for treatment of glioblastoma.
Using sound waves to detect rare cancer cells
Acoustic device can rapidly isolate circulating tumor cells from patient blood samples.
New evidence for how a rare form of liver cancer arises
MIT team finds mechanism by which exposure to vinyl chloride may produce cancerous mutations.
Cerebral curiosity
Graduate student Steven Keating takes a problem-solving approach to his brain cancer.
Study: Prices of cancer drugs have soared since 1995
Researchers find a 10 percent annual increase, after inflation.
New nanodevice defeats drug resistance
Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs.
Taking technology from the lab to the patient
Daniel Anderson wants to bring advances in drug delivery and biomaterials to the clinic.
Interdisciplinary medicine
Senior Yiping Xing’s view of health care draws upon research, public health, and policy.
Biology, driven by data
Newly tenured biological engineer Ernest Fraenkel goes where the numbers lead.
Study details a link between inflammation and cancer
Timing of inflammation determines whether potentially cancerous mutations may arise.
Of yeast, ecology, and cancer
Jeff Gore’s work with baker’s yeast helps ecologists respond to trends, like vanishing fisheries and collapsing honeybee colonies.
In a body that rebels, the search for a delicate balance
Rhodes Scholar Elliot Akama-Garren seeks to harness the power of the immune system to combat cancer.
Proteins drive cancer cells to change states
When RNA-binding proteins are turned on, cancer cells get locked in a proliferative state.
